Amedisys, Inc. (NASDAQ:AMED) Given Average Rating of "Hold" by Analysts

Amedisys, Inc. (NASDAQ:AMED - Get Free Report) has earned an average rating of "Hold" from the six ratings firms that are covering the company, Marketbeat reports. Five analysts have rated the stock with a hold rating and one has issued a buy rating on the company. The average 12-month target price among analysts that have issued ratings on the stock in the last year is $100.75.

Separately, Stephens reaffirmed an "equal weight" rating and set a $101.00 price target on shares of Amedisys in a research report on Tuesday, March 4th.

Institutional Investors Weigh In On Amedisys

Several hedge funds and other institutional investors have recently bought and sold shares of AMED. Blue Trust Inc. grew its stake in shares of Amedisys by 55.1% in the 4th quarter. Blue Trust Inc. now owns 349 shares of the health services provider's stock valued at $34,000 after buying an additional 124 shares during the period. HBW Advisory Services LLC acquired a new stake in Amedisys in the fourth quarter valued at approximately $38,000. Versant Capital Management Inc increased its holdings in shares of Amedisys by 68.5% during the fourth quarter. Versant Capital Management Inc now owns 450 shares of the health services provider's stock valued at $41,000 after acquiring an additional 183 shares in the last quarter. Johnson Financial Group Inc. acquired a new position in shares of Amedisys during the fourth quarter worth approximately $55,000. Finally, KBC Group NV bought a new position in shares of Amedisys in the 3rd quarter worth $63,000. 94.36% of the stock is owned by institutional investors.

Remove Ads

Amedisys Trading Up 0.1 %

Shares of Amedisys stock traded up $0.07 during trading on Friday, hitting $92.16. The company's stock had a trading volume of 307,878 shares, compared to its average volume of 378,579. The stock has a market cap of $3.02 billion, a price-to-earnings ratio of 36.58, a price-to-earnings-growth ratio of 1.78 and a beta of 0.76. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.19 and a quick ratio of 1.19. Amedisys has a 52 week low of $82.15 and a 52 week high of $98.95. The stock has a 50-day moving average price of $92.06 and a two-hundred day moving average price of $92.86.

Amedisys (NASDAQ:AMED - Get Free Report) last issued its quarterly earnings results on Wednesday, February 26th. The health services provider reported $0.96 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.05 by ($0.09). Amedisys had a return on equity of 12.20% and a net margin of 3.57%. The firm had revenue of $598.05 million during the quarter, compared to analyst estimates of $602.38 million. Equities research analysts anticipate that Amedisys will post 4.4 EPS for the current fiscal year.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.